Clinical Trial Update: Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CLR-131 in select B-cell malignancies, with expansion into Waldenström macroglobulinemia. The study status is ACTIVE_NOT_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Lymphoplasmacytic Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Multiple Myeloma
• Small Lymphocytic Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Iopofosine I-131 (CLR-131) (Iopofosine I-131)

Snippet

Sponsor: Cellectar Biosciences, Inc. | Conditions: Waldenstrom Macroglobulinemia, Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING